Mark W. Womack is an organization builder with a track record of delivering unprecedented growth and profit in every role. Mark is BioCina’s Chief Executive Officer, and in his first 9 months at the helm he led BioCina to a 500% YOY increase in sales and a 250% YOY increase in revenue. On February 1, […]
Dr. Massih Tayebi is Founding Partner and Chairman of the Bridgewest Group. Massih and his brother and Co-founder Masood, create novel businesses with leading-edge processes and technology. Inspired by deep tech, Massih incorporates AI with semiconductor tech and software platforms to enable disruptive new solutions. His vision for creating a better tomorrow drives much of
Dr. Masood Tayebi is a Founding Partner and the CEO of the Bridgewest Group. He has a wealth of experience commercializing new technology, particularly in pharmaceutical and biotechnology sectors, as well as the wireless communications sectors. Dr. Tayebi is directly responsible for managing Bridgewest investments in biotechnology and pharmaceuticals, hi-tech and wireless technologies, and software.
Rick Hancock was appointed to the Board of Directors as Executive Chairman in January 2022. Rick has worked in the Biotechnology Industry for over 35 years, including 20 years with various CDMOs in operational and executive roles. Most recently, he served as Interim President and CEO at Avid Bioservices and prior to that, as President
Mike Cicio has worked in the Biotechnology Industry for over 30 years as a hands-on executive with experience with both world class innovators and CDMOs. Experienced in general management of clinical and commercial biotechnology business with a focus on operations. Mike has extensive experience in a variety of biotechnology platforms. Mike received a BS in
